De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option?
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference144 articles.
1. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for non-small cell lung cancer and breast cancer patients with brain metastases;Addeo;Cancer,2008
2. Low-dose metronomic oral administration of vinorelbine in the first-line treatment of elderly patients with metastatic breast cancer;Addeo;Clin. Breast Cancer,2010
3. Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer;Alagizy;Hematol. Oncol. Stem Cell Ther.,2015
4. The prognostic significance of angiogenesis in epithelial ovarian carcinoma;Alvarez;Clin. Cancer Res.,1999
5. Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report;Aurilio;Breast J.,2012
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine;Journal of Oncology Pharmacy Practice;2023-11-28
2. A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy;Journal of Oncology Pharmacy Practice;2023-07-27
3. A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2‐negative metastatic breast cancer;Thoracic Cancer;2023-07-04
4. Immune Targeted Therapies for COVID-19 Infection: A Narrative Review;IRAN J MED SCI;2022
5. Challenges posed by COVID‐19 in cancer patients: A narrative review;Cancer Medicine;2021-12-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3